
Lunai Bioworks Inc. shares surged in early U.S. trading on Wednesday after a company filing showed Nasdaq had confirmed the biotechnology firm was back in compliance with the exchange’s $1 minimum bid-price rule, a key threshold for keeping a listing on the market. The stock was quoted at $4.65, with reported volume of 13.48 million shares, compared with average volume of 1.98 million.
Today’s highest-ranked model selections.
The catalysts most likely to move markets.
A large surprise can reset expectations for household spending and near-term growth, with read-through to Treasuries, USD and cyclical stocks.
Housing remains highly rate-sensitive; the print can move homebuilders, mortgage-sensitive names and the long end of the Treasury curve.
Guidance can influence software multiples and sentiment around U.S. small-business activity.